Neurosurgical Devices
Total Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
1,970
NCT00747253
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2008
Completion: Apr 30, 2010
NCT01651078
Laser Ablation After Stereotactic Radiosurgery
Phase: N/A
Start: Jul 31, 2012
Completion: Aug 31, 2016
NCT02389855
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Start: Feb 28, 2015
NCT02392078
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Start: Oct 31, 2015
Completion: Sep 30, 2023
NCT02820740
Feasibility Study on LITT for Medical Refractory Epilepsy
Start: Apr 21, 2017
Completion: Jun 24, 2019
NCT02880410
Feasibility Study on LITT for Newly Diagnosed Glioblastoma
Start: Aug 15, 2017
Completion: Sep 14, 2018
NCT03176160
LITT Palliative Treatment for Patients With Malignant Gliomas
Role: Collaborator
Start: Jun 30, 2019
Completion: Jun 30, 2022
NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis
Start: Jan 10, 2020
Completion: Dec 1, 2023
NCT05075850
PatiEnt Neuropsychological outcomeS After laseR Ablation
Start: Sep 29, 2021
NCT05124912
REMASTer: REcurrent Brain Metastases After SRS Trial
Start: May 10, 2022
Completion: Oct 31, 2028
NCT06366425
Screening for Chronic Liver Diseases in General Population
Start: Sep 11, 2024
Completion: Jan 1, 2029
Loading map...